Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2009, p. 3097-3099, Vol. 53, No. 7
0066-4804/09/$08.00+0 doi:10.1128/AAC.01552-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Idaiga-oka, Hasama-machi, Oita 879-5593, Japan,1 Chemotherapy Division, Mitsubishi Chemical Medience Corporation, 3-30-1 Shimura, Itabashi-ku, Tokyo 174-8555, Japan,2 Toho University School of Medicine, 4-16-20 Omori-nishi, Ota-ku, Tokyo 143-0015, Japan3
Received 20 November 2008/ Returned for modification 17 December 2008/ Accepted 6 April 2009
Sitafloxacin showed MICs of less than or equal to 0.5 µg/ml against 105 isolates of Helicobacter pylori, including 44 isolates with mutations in the gyrA gene. The highest MICs for garenoxacin and levofloxacin were 8 and 64 times, respectively, higher than the highest MICs observed for sitafloxacin.
Published ahead of print on 20 April 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»